Cargando…

Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

(1) Background and Aims: Efforts to reduce coronary artery disease (CAD) by raising high-density lipoprotein (HDL) cholesterol (HDL-C) have not been uniformly successful. A more important factor than HDL-C may be cellular cholesterol efflux mediated by HDL, which has been shown to be associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritsch, Andreas, Duerr, Angela, Kahler, Patrick, Hunjadi, Monika, Stojakovic, Tatjana, Silbernagel, Guenther, Scharnagl, Hubert, Kleber, Marcus E., März, Winfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700479/ https://www.ncbi.nlm.nih.gov/pubmed/33233452 http://dx.doi.org/10.3390/biomedicines8110524

Ejemplares similares

Independent Effects of Kidney Function and Cholesterol Efflux on Cardiovascular Mortality
por: Ritsch, Andreas, et al.
Publicado: (2022)

Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study—Impact for mortality
por: Woitas, Rainer P., et al.
Publicado: (2017)

Gender- and subgroup-specific sensitivity analysis of alcohol consumption and mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
por: Moissl, Angela P., et al.
Publicado: (2022)

Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
por: Sigruener, Alexander, et al.
Publicado: (2014)

Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
por: Thomas, G. Neil, et al.
Publicado: (2012)

Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study
por: Pusceddu, Irene, et al.
Publicado: (2019)

C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography: The LURIC study
por: Marx, Nikolaus, et al.
Publicado: (2013)

Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study
por: Berger, Martin, et al.
Publicado: (2023)

Telomere length and mortality in the Ludwigshafen Risk and Cardiovascular Health study
por: Pusceddu, Irene, et al.
Publicado: (2018)

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study
por: Scharnagl, Hubert, et al.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
por: Yazdani, Babak, et al.
Publicado: (2022)

Immune Activation and Inflammation in Patients with Cardiovascular Disease Are Associated with Higher Phenylalanine to Tyrosine Ratios: The Ludwigshafen Risk and Cardiovascular Health Study
por: Murr, Christian, et al.
Publicado: (2014)

Data on gender and subgroup specific analyses of omega-3 fatty acids in the Ludwigshafen Risk and Cardiovascular Health Study
por: Kleber, Marcus E., et al.
Publicado: (2016)

HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
por: Hunjadi, Monika, et al.
Publicado: (2020)

Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)
por: Kleber, Marcus E, et al.
Publicado: (2010)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)
por: Lüblinghoff, Nicola, et al.
Publicado: (2009)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
por: Rief, Martin, et al.
Publicado: (2022)

Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound
por: Noflatscher, Maria, et al.
Publicado: (2023)

HDL cholesterol: reappraisal of its clinical relevance
por: März, Winfried, et al.
Publicado: (2017)

Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease
por: Clemens, Robert K., et al.
Publicado: (2021)

Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
por: Silbernagel, Guenther, et al.
Publicado: (2011)

Labordiagnostik von Fettstoffwechselstörungen
por: März, Winfried, et al.
Publicado: (2023)

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography
por: Sommerer, Claudia, et al.
Publicado: (2019)

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
por: Rogacev, Kyrill S., et al.
Publicado: (2016)

Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
por: Metzner, Thomas, et al.
Publicado: (2022)

Investigation of gene-gene interactions in cardiac traits and serum fatty acid levels in the LURIC Health Study
por: Zhou, Jiayan, et al.
Publicado: (2020)

Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity
por: Trakaki, Athina, et al.
Publicado: (2020)

Glycated Hemoglobin Predicts All-Cause, Cardiovascular, and Cancer Mortality in People Without a History of Diabetes Undergoing Coronary Angiography
por: Silbernagel, Guenther, et al.
Publicado: (2011)

Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2019)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Lee, Jane J., et al.
Publicado: (2021)

Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2020)

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
por: Laaksonen, Reijo, et al.
Publicado: (2016)

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes – The VILDIA Score
por: Goliasch, Georg, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j2vv240nugjfojs1mi7h7rgs1v